Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
As of close of business last night, Adverum Biotechnologies Inc’s stock clocked out at $3.23, down -10.03% from its previous closing price of $3.59. In other words, the price has decreased by -$10.03 from its previous closing price. On the day, 0.76 million shares were traded.
Ratios:
To gain a deeper understanding of ADVM’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.73 and its Current Ratio is at 5.73. In the meantime, Its Debt-to-Equity ratio is 1.30 whereas as Long-Term Debt/Eq ratio is at 1.22.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on June 25, 2024, initiated with a Outperform rating and assigned the stock a target price of $25.
On April 30, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $30.
Truist Upgraded its Hold to Buy on July 07, 2022, while the target price for the stock was maintained at $4.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 26 ’25 when Leonard Braden Michael bought 20,407 shares for $5.04 per share. The transaction valued at 102,841 led to the insider holds 125,207 shares of the business.
Leonard Braden Michael bought 16,593 shares of ADVM for $86,089 on Mar 27 ’25. The 10% Owner now owns 141,800 shares after completing the transaction at $5.19 per share. On Apr 22 ’25, another insider, Leonard Braden Michael, who serves as the 10% Owner of the company, bought 300,000 shares for $3.00 each. As a result, the insider paid 900,000 and bolstered with 3,057,526 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 67.48 while its Price-to-Book (P/B) ratio in mrq is 0.95.
Stock Price History:
Over the past 52 weeks, ADVM has reached a high of $10.84, while it has fallen to a 52-week low of $2.64. The 50-Day Moving Average of the stock is -19.50%, while the 200-Day Moving Average is calculated to be -43.70%.
Shares Statistics:
A total of 20.85M shares are outstanding, with a floating share count of 13.87M. Insiders hold about 33.59% of the company’s shares, while institutions hold 60.69% stake in the company.
